Cargando…
Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
Neurofibrillary tangles (NFT) is one of the hallmarks of Alzheimer’s disease (AD). Recent research suggests that pretangle tau, the soluble precursor of NFT, is an initiator for AD pathogenesis, thus targeting pretangle tau pathology may be a promising early intervention focus. The bidirectional com...
Autores principales: | Flynn, Cassandra M., Yuan, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073452/ https://www.ncbi.nlm.nih.gov/pubmed/37034173 http://dx.doi.org/10.3389/fnins.2023.1159314 |
Ejemplares similares
-
Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies
por: Medina, Miguel, et al.
Publicado: (2011) -
GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020) -
Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β
por: Hole, Katriona L., et al.
Publicado: (2021) -
Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice
por: Zhang, Yao, et al.
Publicado: (2014) -
Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits
por: Rodríguez-Matellán, Alberto, et al.
Publicado: (2020)